Sensing cytoplasmic danger signals by the inflammasome.
BACKGROUND
The innate immune system depends on molecules collectively known as pattern recognition receptors (PRRs) to survey the extracellular space and the cytoplasm for the presence of dangerous pathogens, pathogen-derived molecules, or even self-derived molecular danger signals, which arise from tissue damage. Absent in melanoma 2 (AIM2) is a newly discovered PRR involved in the sensing of dangerous cytosolic DNA produced by infection with DNA viruses.


CONCLUSIONS
Remarkably, recent studies in AIM2-deficient mice showed that AIM2 is uniquely involved in sensing infection with the intracellular bacteria Francisella tularensis and subsequently triggering caspase-1-mediated pro-inflammatory cytokine production and macrophage cell death, which activate other components of the immune system and eliminate the infected macrophages. Here, we provide an overview of our current understanding of the role of AIM2 in innate immunity against F. tularensis in particular, and how infection of macrophages with this pathogen is thought to activate AIM2.
Alnemri
Emad S
ES
Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA. E_Alnemri@mail.jci.tju.edu
D003593:Cytoplasm; D004268:DNA-Binding Proteins; D005604:Francisella tularensis / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate; D008264:Macrophages / Q000382:microbiology; D009687:Nuclear Proteins / Q000276:immunology*; D051192:Receptors, Pattern Recognition / Q000276:immunology*; D015398:Signal Transduction / Q000276:immunology*
C410167:AIM2 protein, human; D004268:DNA-Binding Proteins; D009687:Nuclear Proteins; D051192:Receptors, Pattern Recognition
Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14578-83
16983090
Mol Cell. 2003 Feb;11(2):529-41
12620239
Immunity. 2008 Jun;28(6):735-9
18549796
Nat Rev Immunol. 2009 Aug;9(8):535-42
19556980
Cell Microbiol. 2005 Jul;7(7):969-79
15953029
J Interferon Cytokine Res. 2010 Jun;30(6):371-80
20187776
Nature. 2008 Feb 7;451(7179):725-9
18256672
J Exp Med. 2005 Oct 17;202(8):1043-9
16230474
Science. 2009 Feb 20;323(5917):1057-60
19131592
Eur J Immunol. 2008 Jan;38(1):204-15
18085665
Nature. 2008 Mar 6;452(7183):103-7
18288107
Cell Microbiol. 2007 Nov;9(11):2543-51
17662071
Nat Rev Immunol. 2007 Mar;7(3):179-90
17318230
Nature. 2006 Jul 6;442(7098):39-44
16823444
Infect Immun. 2009 May;77(5):1757-73
19237528
Lung. 2000;178(2):91-104
10773135
Nature. 2009 Mar 26;458(7237):509-13
19158676
J Exp Med. 2007 May 14;204(5):987-94
17452523
Nat Rev Immunol. 2007 May;7(5):353-64
17457343
Annu Rev Immunol. 2009;27:229-65
19302040
Nature. 2007 Jul 26;448(7152):501-5
17618271
Biochem J. 2009 Apr 28;420(1):1-16
19382893
Nat Immunol. 2010 May;11(5):395-402
20351692
Cell Death Differ. 2007 Sep;14(9):1590-604
17599095
Nat Immunol. 2010 Jan;11(1):63-9
19915568
Nat Rev Immunol. 2010 Feb;10(2):123-30
20098460
J Biol Chem. 2002 Jun 14;277(24):21119-22
11967258
Nat Immunol. 2010 May;11(5):385-93
20351693
Nature. 2009 Mar 26;458(7237):514-8
19158675
Cell. 2006 Feb 24;124(4):783-801
16497588
Nat Immunol. 2009 Oct;10(10):1065-72
19609254
Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5477-82
18375758
Cell Death Differ. 2006 May;13(5):816-25
16410796
Cell. 2009 Aug 7;138(3):576-91
19631370
Trends Microbiol. 2004 Apr;12(4):162-9
15051066
Nat Immunol. 2009 Mar;10(3):266-72
19158679
Semin Immunol. 2009 Aug;21(4):199-207
19539499
Immunity. 2008 Mar;28(3):285-7
18341998
Mol Microbiol. 1998 Jul;29(1):247-59
9701818